Denka Co (DIK) Price & Analysis

Compare

0 Followers

DIK Stock Chart & Stats

€14.50

-€0.30(-2.21%)

At close: Jan 08 4:00 PM EST

€14.50

-€0.30(-2.21%)

Day’s Range― - ―

52-Week Range€10.50 - €19.60

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

€1.65B

Enterprise Value€495.20B

Total Cash (Recent Filing)€42.55B

Total Debt (Recent Filing)€222.64B

Price to Earnings (P/E)―

Beta0.51

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding88,555,840

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.07

Price to Book (P/B)0.62

Price to Sales (P/S)0.46

P/FCF Ratio-4.47

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Diversified End-market ExposureDenka's exposure across electronics, mobility, construction, packaging and healthcare creates durable demand diversification. Multiple end markets reduce single-sector cyclicality and support steady order flows for specialty materials, helping revenue resilience even if one market softens over a 2-6 month horizon.

Manageable Balance Sheet LeverageA moderate debt-to-equity (0.74) and equity ratio near 45% provide financial flexibility to fund working capital and targeted capex without extreme leverage risk. This structural stability supports investment and operational continuity through business cycles over the coming months.

Specialty Product Focus And B2B Customer RelationshipsThe company's emphasis on higher value-added specialty materials and B2B sales creates durable competitive advantages: product qualification barriers, technical switching costs, and closer customer ties. These factors sustain pricing power and recurring revenues across quarters.

Bears Say

Deteriorating Free Cash FlowWorsening negative free cash flow undermines the firm's ability to self-fund capex, service debt, and sustain dividends. Over several months this reduces optionality for strategic investments or buffer for cyclical downturns, increasing reliance on external financing or cost cuts.

Negative Net Income And Thin Operating MarginsA decline in revenue coupled with negative net income and a low EBIT margin signals weakened profitability. Persistent margin pressure limits reinvestment, reduces ability to absorb input-cost shocks, and harms long-run competitive positioning unless structural margin improvement occurs.

Severe EPS Deterioration And Negative ReturnsA sharp EPS decline and negative ROE reflect earnings stress and capital inefficiency. Over months this erodes stakeholder confidence, constrains management flexibility on strategic initiatives, and may force operational restructuring to restore returns to acceptable levels.

Denka Co News

Denka Weighs 2027 Spin-off of Styrene Business to Sharpen Portfolio

An update from Denka Co ( ($JP:4061) ) is now available. Denka has begun formally reviewing a potential...

5d ago

Denka Revamps Mission 2030 Plan to Rebuild Earnings and Enter New Growth Phase

Denka Co ( ($JP:4061) ) just unveiled an announcement. Denka has updated its Mission 2030 management plan with...

5d ago

Denka pivots “Mission 2030” to earnings rebuild with Phase 2 plan

Denka Co ( ($JP:4061) ) has issued an update. Denka has launched Phase 2 of its “Mission 2030”...

5d ago

Denka Sets Up Flowers Subsidiary for Joint Tender Offer for KAINOS Laboratories

Denka Co ( ($JP:4061) ) has shared an announcement. Denka has set up a wholly owned subsidiary, Flowers...

23d ago

Denka Books ¥14.2 Billion Extraordinary Loss on U.S. Elastomer Business Liquidation

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka Company Limited will book an extraordinary...

26d ago

Denka Reshapes Executive Lineup and Roles to Strengthen Operations and Innovation

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka Company Limited has announced a reshuffle...

26d ago

Denka Advances Shutdown and Cost Controls at U.S. Chloroprene Rubber Unit

Denka Co ( ($JP:4061) ) just unveiled an announcement. Denka reported on the ongoing suspension of production at...

26d ago

Denka Lifts Profit Outlook as Nine-Month Earnings Surge Despite Lower Sales

An announcement from Denka Co ( ($JP:4061) ) is now available. Denka reported consolidated net sales of ¥290.8...

26d ago

DIK Upcoming Earnings Report: What to Expect?

Denka Co (DIK) is scheduled to report 3rd quarter earnings on 02/06/2026. Regarding Q3 estimates, Wall Street analysts...

27d ago

Denka Records Extraordinary Loss Amid Strategic Adjustments

The latest update is out from Denka Co ( ($JP:4061) ). Denka Company Limited announced an extraordinary loss...

4M ago

DIK FAQ

What was Denka Co Ltd’s price range in the past 12 months?

Denka Co Ltd lowest stock price was €10.50 and its highest was €19.60 in the past 12 months.

What is Denka Co Ltd’s market cap?

Denka Co Ltd’s market cap is €1.65B.

When is Denka Co Ltd’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Denka Co Ltd’s earnings last quarter?

Currently, no data Available

Is Denka Co Ltd overvalued?

According to Wall Street analysts Denka Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Denka Co Ltd pay dividends?

Denka Co Ltd does not currently pay dividends.

What is Denka Co Ltd’s EPS estimate?

Denka Co Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Denka Co Ltd have?

Denka Co Ltd has 88,555,840 shares outstanding.

What happened to Denka Co Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Denka Co Ltd?

Currently, no hedge funds are holding shares in DE:DIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Denka Co Ltd

Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.